Granisetron Transdermal Patch and Mefloquine: Interaction Details
- Mefloquine
- Lariam
- Granisetron Transdermal Patch
- SancusoSustolGranisol
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Granisetron Transdermal Patch and Mefloquine interaction:
Granisetron Transdermal Patch
- Sancuso
- Sustol
- Granisol
What Happens When You Take Granisetron Transdermal Patch With Mefloquine
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
QT interval prolongation is a recognized possibility with both granisetron and mefloquine.12 Because their effects on the could be , and because this raises the risk of serious cardiac events, the drugs should be used together with caution.1 When combined treatment cannot be avoided, patients should be monitored closely for QT interval prolongation.
The Granisetron Transdermal Patch and Mefloquine Interaction, Explained
Both mefloquine (an anti-malaria medicine) and the granisetron patch (used to prevent nausea from chemotherapy) can affect the heart's electrical rhythm. This is called . When taken together, these effects could add up and, in rare cases, lead to a serious irregular heartbeat.
This concern is theoretical, meaning it is based on how the drugs work rather than on many reported cases. Keep taking both as prescribed and tell your pharmacist or doctor about every medicine you use. Your care team may check your heart rhythm with an to keep you safe. Let them know right away if you feel faint, dizzy, or notice a racing or fluttering heartbeat.
() between mefloquine and granisetron (transdermal). Both agents are associated with QT prolongation, so combined use may raise the risk of or other serious ventricular . Evidence is theoretical; onset is unspecified. Severity is rated major.
- Use caution; avoid the combination if alternatives exist.
- If is required, obtain a baseline and monitor closely for QT prolongation.
- Correct electrolytes (K, Mg) and review other QT-prolonging drugs and risk factors.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Granisetron Transdermal Patch and Mefloquine Interact
The likely mechanism
effects on
How to Manage the Granisetron Transdermal Patch and Mefloquine Interaction
Your care team can manage this combination with careful monitoring.
- Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise.
- If you need both, your team may monitor your heart rhythm more closely with ECGs to watch the .
- Your team may also consider whether another option is suitable for you.
- Tell your pharmacist or prescriber about all other medicines and supplements you take, since others can also affect heart rhythm.
- Report fainting, severe dizziness, or a pounding or irregular heartbeat promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Granisetron Transdermal Patch or Mefloquine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Granisetron Transdermal Patch and Mefloquine: Common Questions
How serious is the Granisetron Transdermal Patch and Mefloquine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Granisetron Transdermal Patch and Mefloquine interaction managed?
Your care team can manage this combination with careful monitoring. Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise. If you need both, your team may monitor your heart rhythm more closely with ECGs to watch the . Your team may also consider whether another option is suitable for you. Tell your pharmacist or prescriber about all other medicin… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Granisetron Transdermal Patch and Mefloquine Interaction
Ask in your own words about taking Granisetron Transdermal Patch and Mefloquine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: KYTRIL(R) IV injection, granisetron HCl IV injection. Genentech USA, Inc, South San Francisco, CA, 2011.
- Product Information: LARIAM(R) oral tablets, mefloquine hcl oral tablets. Roche Laboratories, Inc, Nutley, NJ, 2009.
Other Serious Interactions of Granisetron Transdermal Patch and Mefloquine
Also serious with Mefloquine
- IsradipineContraindicated
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PimozideContraindicated
Also serious with Granisetron Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mefloquine
- Activated CharcoalMajor
- GinkgoModerate
- MelatoninModerate
- Slippery ElmModerate
- GlucomannanModerate
- BiofeedbackModerate
- Coffee CharcoalModerate
- DendrobiumModerate
- + 15 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.